Specialty Pharmacy Programs & Services
SYRACUSE, NY, June 2, 2016 - Delta Marketing Dynamics (DMD) announces the release of “Specialty Pharmacy Programs & Services: Core, Enhanced, and Future Considerations” , a whitepaper (the second in a DMD Specialty Pharmaceutical whitepaper three-part series) based on the analysis of executive-level interviews and secondary research conducted by DMD. It is intended for use by both Specialty Pharmacy Providers (SPPs) and Specialty Pharmaceutical manufacturers (SPMs) to help each optimize the patients journey for important, complicated, and often costly specialty medicines. The topics covered in this series will be focused on core issues challenging specialty pharmaceutical stakeholders today and in the future.
Specialty pharmaceuticals are a core part of the US healthcare solution. While initially focused on rare diseases and products with challenging handling requirements, the definition for specialty pharmaceuticals is broadening. Estimates suggest that future growth in specialty drug spending could quadruple by 2020, reaching about $400 billion or 9.1% of national health care spending.1
“Due to the high cost and often complex treatment that goes along with specialty medicines, it is extremely important that the services and programs focused on patients are optimized.” said James Sharples, Vice President at Delta Marketing Dynamics, a leading marketing research consultancy in the healthcare space. “There is a fair amount of confusion as to what services are considered basic versus enhanced, and also what gaps are still present.”
For this reason, DMD has analyzed the services/programs offered to help improve outcomes for patients using specialty pharmaceuticals, supplementing previous secondary research with recent interviews of key executives in both SPM and SPP organizations. Key topics on this services-focused whitepaper include:
- What are core versus enhanced SPP services/programs?
- What services/programs are currently being developed/future SPP services?
- Where are the gaps in SPP services & programs?
1. UnitedHealth Group. The Growth of Specialty Pharmacy. Issue Brief, April 2014
Delta Marketing Dynamics is a market research consultancy with a long tradition of helping clients “Know More and Connect Better”, especially in the pharmacy space. For over 40 years DMD has offered key insights and deeper understanding of distribution patterns for many large and expensive brands distributed through the specialty channel. With direct access to top specialty pharmacies in the US, DMD offers customized research and syndicated options to help you assess and compare specialty distribution and programs. For more information or to access this whitepaper, please call James Sharples at 315-671-0811 or visit our website at http://deltamarketingdynamics.com/specialty/whitepaper20162/